降钙素原、C反应蛋白清除率对脓毒性休克患者的预后价值

余长升, 马艳红, 辛晓婷. 降钙素原、C反应蛋白清除率对脓毒性休克患者的预后价值[J]. 临床急诊杂志, 2020, 21(6): 482-487. doi: 10.13201/j.issn.1009-5918.2020.06.013
引用本文: 余长升, 马艳红, 辛晓婷. 降钙素原、C反应蛋白清除率对脓毒性休克患者的预后价值[J]. 临床急诊杂志, 2020, 21(6): 482-487. doi: 10.13201/j.issn.1009-5918.2020.06.013
YU Changsheng, MA Yanhong, XIN Xiaoting. Prognostic value of procalcitonin and C-reactive protein clearance rate in septic shock patients[J]. J Clin Emerg, 2020, 21(6): 482-487. doi: 10.13201/j.issn.1009-5918.2020.06.013
Citation: YU Changsheng, MA Yanhong, XIN Xiaoting. Prognostic value of procalcitonin and C-reactive protein clearance rate in septic shock patients[J]. J Clin Emerg, 2020, 21(6): 482-487. doi: 10.13201/j.issn.1009-5918.2020.06.013

降钙素原、C反应蛋白清除率对脓毒性休克患者的预后价值

详细信息
    通讯作者: 余长升,E-mail:380655092@qq.com
  • 中图分类号: R631.2

Prognostic value of procalcitonin and C-reactive protein clearance rate in septic shock patients

More Information
  • 目的:探讨降钙素原清除率(PCT-c)、C反应蛋白清除率(CRP-c)在脓毒性休克患者28 d内病死率的价值。方法:选取我院在2016-01—2019-02期间收治的223例脓毒性休克患者,根据28 d内的死亡事件分为生存组(165例)与死亡组(58例)。采用酶联荧光法测定血清PCT浓度,采用免疫比浊法测定血清CRP浓度。之后在第2天、第3天、第5天以同样方式测定血清PCT及CRP浓度。计算PCT-c2/1、PCT-c3/1、PCT-c5/1、CRP-c2/1、CRP-c3/1、CRP-c5/1。结果:脓毒性休克患者病死率为26.0%。生存组患者的SOFA评分低于死亡组患者,差异有统计学意义(P<0.05)。死亡组患者第1天、第2天、第3天、第5天的血清PCT及CRP浓度均高于生存组患者,差异有统计学意义(P<0.05)。PCT-c3/1的AUC为0.797,最佳截断值为0.68;CRP-c3/1的AUC为0.802,最佳截断值为0.55。SOFA评分(OR:2.261,95%CI:1.738~2.940)、PCT-c3/1≤0.68(OR:3.544,95%CI:2.324~6.968)及CRP-c3/1≤0.55(OR:3.874,95%CI:1.065~7.099)为脓毒性休克患者死亡的独立危险因素(P<0.05)。结论:PCT-c及CRP-c对于预测28 d内脓毒性休克患者病死率的价值相当且均具有较高的临床价值,建议将其纳入常规的监测指标中,进一步完善该类患者治疗指导方案。
  • 加载中
  • [1]

    蒋道慧,张琳,彭松.每搏量变异度在预测老年脓毒性休克患者容量反应性中的价值[J].临床急诊杂志,2017,18(10):783-786.

    [2]

    Bloos F,Marshall JC,Dellinger RP,et al.Multinational,observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation:a multicenter observational study[J].Critical Care,2011,15(2):R88.

    [3]

    Grigoras I,Branisteanu DD,Ungureanu D,et al.Early dynamics of leptin plasma level in surgical critically ill patients.a prospective comparative study[J].Chirurgia,2014,109(1):66-72.

    [4]

    Su LX,Feng L,Song Q,et al.Diagnostic value of dynamics serum sCD163,sTREM-1,PCT,and CRP in differentiating sepsis,severity assessment,and prognostic prediction[J].Mediators Inflamm,2013,2013:1-9.

    [5]

    Andriolo BN,Andriolo RB,Salomao R,et al.Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis,severe sepsis or septic shock.[J].Cochrane Database Syst Rev,2017,2017(1):CD010959.

    [6]

    Dellinger RP,Mitchell M.Levy;Andrew Rhodes,et al;The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2):165-228.

    [7]

    Gai L,Tong Y,Yan BQ.Research on the diagnostic effect of PCT level in serum on patients with sepsis due to different pathogenic causes[J].Eur Rev Med Pharmacol Sci,2018,22(13):4238-4242.

    [8]

    Oliveira CF,Botoni FA,Oliveira CRA,et al.Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis:a randomized trial[J].Crit Care Med,2013,41(10):2336-2343.

    [9]

    Yoshinaga R,Doi Y,Ayukawa K,et al.High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department:a retrospective cohort study[J].BMJ Open,2017,7(10):e015112.

    [10]

    Garnacho-Montero J,Huici-Moreno MJ,Gutiérrez-Pizarraya A,et al.Prognostic and diagnostic value of eosinopenia,C-reactive protein,procalcitonin,and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis[J].Crit Care,2014,18(3):R116.

    [11]

    Jensen JU,Heslet L,Jensen TH,et al.Procalcitonin increase in early identification of critically ill patients at high risk of mortality[J].Critical Care Med,2006,34(10):2596-2602.

    [12]

    Wacker,Christina,Prkno,et al.Procalcitonin as a diagnostic marker for sepsis:a systematic review and;meta-analysis[J].Lancet Infectious Diseases,2013,13(5):426-435.

    [13]

    Wu Q,Nie J,Wu FX,et al.Prognostic Value of High-Sensitivity C-Reactive Protein,Procalcitonin and Pancreatic Stone Protein in Pediatric Sepsis[J].Medical Science Monitor,2017,23:1533-1539.

    [14]

    Ruiz-Rodríguez JC,Caballero J,Ruiz-Sanmartin A,et al.Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock.A prospective pilot study[J].Medicina Intensiva,2012,36(7);475-480.

    [15]

    Azevedo JD,Torres O,Malafaia O.Procalcitonin as a prognostic biomarker of severe sepsis and septic shock[J].Rev Col Bras Cir,2013,39(6):456-461.

    [16]

    Suberviola B,Castellanos-Ortega A,González-Castro A,ey al.Prognostic value of procalcitonin,C-reactive protein and leukocytes in septic shock[J].Medicina Intensiva,2012,36(3):177-184

    [17]

    Schuetz P,Maurer P,Punjabi V,et al.Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients[J].Critical Care,2013,17(3):R115.

    [18]

    Cui N,Zhang H,Chen Z,et al.Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock:retrospective analysis of 59 cases[J].J Int Med Res,2019,47(4):1573-1579.

    [19]

    李娜,李瑞.C-反应蛋白下降率对判断严重脓毒症患者预后的作用[J].新疆医科大学学报,2014,37(08):1005-1007.

  • 加载中
计量
  • 文章访问数:  131
  • PDF下载数:  198
  • 施引文献:  0
出版历程
收稿日期:  2020-01-15

目录